RNF13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.162200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.259600E-01
Normal-vs-Stage2
5.480800E-01
Normal-vs-Stage3
1.185390E-01
Normal-vs-Stage4
8.331000E-01
Stage1-vs-Stage2
8.291400E-01
Stage1-vs-Stage3
1.124430E-01
Stage1-vs-Stage4
8.927400E-01
Stage2-vs-Stage3
1.954020E-01
Stage2-vs-Stage4
7.382000E-01
Stage3-vs-Stage4
2.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.506400E-01
Normal-vs-AfricanAmerican
9.499400E-01
Normal-vs-Asian
3.656600E-01
Caucasian-vs-AfricanAmerican
2.400200E-01
Caucasian-vs-Asian
5.658000E-01
AfricanAmerican-vs-Asian
2.644800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.330800E-01
Normal-vs-Female
6.525600E-01
Male-vs-Female
1.094440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.931000E-01
Normal-vs-Age(41-60Yrs)
9.088600E-01
Normal-vs-Age(61-80Yrs)
3.714000E-01
Normal-vs-Age(81-100Yrs)
4.955800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.199000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.624000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.521400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.400500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.866400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.071600E-01
Normal-vs-Daily Drinker
9.745900E-02
Normal-vs-Weekly Drinker
2.819600E-01
Normal-vs-Occasional Drinker
9.811400E-01
Normal-vs-Social Drinker
7.979000E-01
Non Drinker-vs-Daily Drinker
3.692400E-01
Non Drinker-vs-Weekly Drinker
7.739600E-01
Non Drinker-vs-Occasional Drinker
8.121600E-02
Non Drinker-vs-Social Drinker
1.135770E-01
Daily Drinker-vs-Weekly Drinker
6.925200E-01
Daily Drinker-vs-Occasional Drinker
2.568200E-02
Daily Drinker-vs-Social Drinker
3.432100E-02
Weekly Drinker-vs-Occasional Drinker
1.083400E-01
Weekly Drinker-vs-Social Drinker
1.722010E-01
Occasional Drinker-vs-Social Drinker
7.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.041900E-02
Normal-vs-Grade 2
3.800500E-03
Normal-vs-Grade 3
7.782500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.530500E-02
Grade 1-vs-Grade 3
4.786200E-02
Grade 1-vs-Grade 4
7.041900E-02
Grade 2-vs-Grade 3
6.159600E-01
Grade 2-vs-Grade 4
3.800500E-03
Grade 3-vs-Grade 4
7.782500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.728200E-01
Normal-vs-NonDiabetic
4.502800E-01
Diabetic-vs-NonDiabetic
1.969820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.994000E-02
Normal-vs-NoPancreatitis
4.693000E-01
Pancreatitis-vs-NoPancreatitis
2.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.820000E-01
Normal-vs-N1
5.606400E-01
N0-vs-N1
5.724000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.695200E-01
Normal-vs-TP53-NonMutant
4.196000E-01
TP53-Mutant-vs-TP53-NonMutant
2.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
